224 related articles for article (PubMed ID: 7150475)
1. Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNU.
Workman P; Twentyman PR
Br J Cancer; 1982 Aug; 46(2):249-59. PubMed ID: 7150475
[TBL] [Abstract][Full Text] [Related]
2. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
Siemann DW
Br J Cancer; 1982 Feb; 45(2):272-81. PubMed ID: 6460517
[TBL] [Abstract][Full Text] [Related]
3. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
Mulcahy RT; Siemann DW
Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
[TBL] [Abstract][Full Text] [Related]
4. In vivo combination of misonidazole and the chemotherapeutic agent CCNU.
Siemann DW
Br J Cancer; 1981 Mar; 43(3):367-77. PubMed ID: 7225287
[TBL] [Abstract][Full Text] [Related]
5. In vivo potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by the radiation sensitizer benznidazole.
Siemann DW; Morrissey S; Wolf K
Cancer Res; 1983 Mar; 43(3):1010-3. PubMed ID: 6825075
[TBL] [Abstract][Full Text] [Related]
6. Enhancement by electron-affinic agents of the therapeutic effects of cytotoxic agents against the KHT tumor: structure-activity relationships.
Workman P; Twentyman PR
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):623-6. PubMed ID: 7107385
[TBL] [Abstract][Full Text] [Related]
7. Misonidazole and CCNU: further evidence for a pharmacokinetic mechanism of chemosensitization and therapeutic gain.
Lee FY; Workman P
Br J Cancer; 1984 May; 49(5):579-85. PubMed ID: 6722006
[TBL] [Abstract][Full Text] [Related]
8. Effect of misonidazole or metronidazole pretreatment on the response of the RIF-1 mouse sarcoma to melphalan, cyclophosphamide, chlorambucil and CCNU.
Twentyman P; Workman P
Br J Cancer; 1982 Mar; 45(3):447-55. PubMed ID: 7073938
[TBL] [Abstract][Full Text] [Related]
9. Effect of partition coefficient on the ability of nitroimidazoles to enhance the cytotoxicity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
Hirst DG; Brown JM; Hazlehurst JL
Cancer Res; 1983 May; 43(5):1961-5. PubMed ID: 6682009
[TBL] [Abstract][Full Text] [Related]
10. In vivo interaction between radiation and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the absence or presence of misonidazole in mice.
Siemann DW; Maddison K; Wolf K; Hill SA; Keng PC
Cancer Res; 1985 Jan; 45(1):198-202. PubMed ID: 3965132
[TBL] [Abstract][Full Text] [Related]
11. The effect in the KHT sarcoma of CCNU and MISO on cell cycle progression evaluated by flow-cytometry.
Hill SA; Bauer KD; Keng PC; Siemann DW
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1619-22. PubMed ID: 6480450
[TBL] [Abstract][Full Text] [Related]
12. Chemosensitization by lipophilic nitroimidazoles.
Twentyman PR; Workman P
Br J Cancer; 1983 Jul; 48(1):17-26. PubMed ID: 6871076
[TBL] [Abstract][Full Text] [Related]
13. Enhanced tumor responses through therapies combining CCNU, MISO and radiation.
Siemann DW; Hill SA
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1623-6. PubMed ID: 6480451
[TBL] [Abstract][Full Text] [Related]
14. Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice.
Lee FY; Workman P
Br J Cancer; 1983 May; 47(5):659-69. PubMed ID: 6849803
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain.
Hirst DG; Brown JM; Hazlehurst JL
Br J Cancer; 1982 Jul; 46(1):109-16. PubMed ID: 7201845
[TBL] [Abstract][Full Text] [Related]
16. Chemopotentiation in vivo: no loss of sensitization with fractionation.
Hill SA; Siemann DW
Br J Cancer; 1984 Oct; 50(4):509-17. PubMed ID: 6487517
[TBL] [Abstract][Full Text] [Related]
17. Altered pharmacokinetics in the mechanism of chemosensitization: effects of nitroimidazoles and other chemical modifiers on the pharmacokinetics, antitumour activity and acute toxicity of selected nitrogen mustards.
Lee FY; Workman P
Cancer Chemother Pharmacol; 1986; 17(1):30-7. PubMed ID: 3698174
[TBL] [Abstract][Full Text] [Related]
18. Effect of pretreatment with phenobarbital or SKF 525A on the toxicity and antitumor activity of lomustine.
Siemann DW
Cancer Treat Rep; 1983 Mar; 67(3):259-65. PubMed ID: 6831472
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of CCNU activity by misonidazole in metastases.
Siemann DW; Alliet KL
Clin Exp Metastasis; 1987; 5(1):57-63. PubMed ID: 3829497
[TBL] [Abstract][Full Text] [Related]
20. The effect of radiosensitizer pretreatment on the response of the RIF-1 mouse sarcoma to cytotoxic drugs.
Twentyman PR; Workman P
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):611-3. PubMed ID: 7107382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
